Blue-Blocking IOLs in Combined Surgery
Although commonly used in cataract surgery, the use of the blue light-filter IOLs in vitrectomy combined with cataract surgery has not been reported yet. A prospective controlled clinical trial was designed to evaluate the effect of the blue light-filter IOL on the surgeon's ability to perform specific vitreoretinal procedures and on the patients' outcome.
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
|Official Title:||Blue Light-Filter IOLs in Vitrectomy Combined With Cataract Surgery: Results of a Randomized Controlled Clinical Trial.|
- intraoperative conditions for the surgeon (scaled questionnaire) and patients´ outcome
- complication rates and vitreoretinal diagnoses
|Study Start Date:||October 2004|
|Study Completion Date:||March 2006|
Procedure: combined surgery
Sixty patients were randomly assigned to receive a UV-filter IOL (transparent IOL group) or a blue light-filter IOL (yellow IOL group) combined with a vitreoretinal procedure.
Outcome measures were intraoperative conditions for the surgeon, complication rates, the functional outcome and vitreoretinal diagnoses.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00537992
|Principal Investigator:||Susanne Binder, Prof., MD||Ludwig Boltzmann Institute for Retinology and Biomicroscopic Laser Surgery|
|Study Director:||Christiane I Falkner-Radler, MD||Ludwig Boltzmann Institute for Retinology and Biomicroscopic Laser Surgery|